Effect of oral alkali supplementation on progression of chronic kidney disease

Current Hypertension Reviews

Volumn 10, Issue 2, 2014, Pages 112-120

  Gaggl, Martina ^a   Sliber, Christopher ^a   Sunder Plassmann, Gere ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acid base; Acidosis; Alkali; Bicarbonate; Chronic kidney disease; Progression

Indexed keywords

ALKALI; BICARBONATE; INSULIN; PROTEIN;

ALKALOSIS; ARTICLE; BICARBONATE BLOOD LEVEL; BONE DISEASE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; DIET THERAPY; DISEASE COURSE; DISEASE EXACERBATION; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; METABOLIC ACIDOSIS; MORTALITY; MUSCLE ATROPHY; MUSCLE METABOLISM; NUCLEIC ACID BASE SUBSTITUTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; RETROSPECTIVE STUDY; ACID BASE BALANCE; ACIDOSIS, RENAL TUBULAR; BONE; COMPLICATION; DRUG EFFECTS; META ANALYSIS (TOPIC); METABOLISM; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL INSUFFICIENCY, CHRONIC; SKELETAL MUSCLE; TREATMENT OUTCOME;

ACID-BASE EQUILIBRIUM; ACIDOSIS, RENAL TUBULAR; BONE AND BONES; HUMANS; HYPERTENSION; INSULIN RESISTANCE; META-ANALYSIS AS TOPIC; MUSCLE, SKELETAL; PROTEINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; SODIUM BICARBONATE; TREATMENT OUTCOME;

EID: 84921767169     PISSN: 15734021     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/1573402111666141231123314     Document Type: Article

References (77)

1. Goodman AD, Lemann J Jr, Lennon EJ, Relman AS. Production, Excretion, and Net Balance of Fixed Acid in Patients with Renal Acidosis. J Clin Invest 1965; 44: 495-506.
2. Kurtz I, Maher T, Hulter HN, Schambelan M, Sebastian A. Effect of diet on plasma acid-base composition in normal humans. Kidney Int 1983; 24: 670-80.
3. Lemann J Jr, Bushinsky DA, Hamm LL. Bone buffering of acid and base in humans. Am J Physiol Renal Physiol 2003; 285: F811-32.
4. Curthoys NP, Moe OW. Proximal Tubule Function and Response to Acidosis. Clin J Am Soc Nephrol 2014; 9(9): 1627-38.
5. Nowik M, Lecca MR, Velic A, Rehrauer H, Brändli AW, Wagner CA. Genome-wide gene expression profiling reveals renal genes regulated during metabolic acidosis. Physiol Genomics 2008; 32: 322-34.
6. Oh MS. New perspectives on acid-base balance. Semin Dial 2000; 13: 212-9.
7. Madias NE, Adrogué HJ, Horowitz GL, Cohen JJ, Schwartz WB. A redefinition of normal acid-base equilibrium in man: carbon dioxide tension as a key determinant of normal plasma bicarbonate concentration. Kidney Int 1979; 16: 612-8.
8. Kumar V, Karon BS. Comparison of measured and calculated bicarbonate values. Clin Chem 2008; 54: 1586-7.
9. Kraut JA, Kurtz I. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis 2005; 45: 978-93.
10. Peixoto AJ, Alpern RJ. Treatment of severe metabolic alkalosis in a patient with congestive heart failure. Am J Kidney Dis 2013; 61: 822-7.
11. Henger A, Tutt P, Riesen WF, Hulter HN, Krapf R. Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients. J Lab Clin Med 2000; 136: 379-89.
12. Liamis G, Milionis HJ, Elisaf M. Pharmacologically-induced metabolic acidosis: a review. Drug Saf 2010; 33: 371-91.
13. Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol 2010; 6: 274-85.
14. Krieger NS, Frick KK, Bushinsky DA, Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens 2004; 13: 423-36.
15. Kalantar-Zadeh K, Mehrotra R, Fouque D, Kopple JD. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial 2004; 17: 455-65.
16. Freund DM, Prenni JE, Curthoys NP. Response of the mitochondrial proteome of rat renal proximal convoluted tubules to chronic metabolic acidosis. Am J Physiol Renal Physiol 2013; 304: F145-55.
17. Lotspeich, WD. Renal Hypertrophy in Metabolic Acidosis and Its Relation to Ammonia Excretion. Am J Physiol 1965; 208: 1135-42.
18. Namba T, Takabatake Y, Kimura T, et al. Autophagic Clearance of Mitochondria in the Kidney Copes with Metabolic Acidosis. J Am Soc Nephrol 2014; 25(10): 2254-66.
19. Nath KA, Hostetter MK, Hostetter TH. Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 1985; 76: 667-75.
20. Wesson DE, Nathan T, Rose T, Simoni J, Tran RM. Dietary protein induces endothelin-mediated kidney injury through enhanced intrinsic acid production. Kidney Int 2007; 71: 210-7.
21. Wesson DE, Jo CH, Simoni J. Angiotensin II receptors mediate increased distal nephron acidification caused by acid retention. Kidney Int 2012; 82(11): 1184-94.
22. Wesson DE, Simoni J. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet. Kidney Int 2010; 78: 1128-35.
23. Boedtkjer E, Aalkjaer C. Disturbed acid-base transport: an emerging cause of hypertension. Front Physiol 2013; 4: 388.
24. Lemann J, Jr, Litzow JR, Lennon EJ. The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest 1966; 45: 1608-14.
25. Kraut JA, Madias NE. Consequences and therapy of the metabolic acidosis of chronic kidney disease. Pediatr Nephrol 2011; 26: 19-28.
26. Krieger NS, Sessler NE, Bushinsky DA. Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol 1992; 262: F442-8.
27. Krieger NS, Parker WR, Alexander KM, Bushinsky DA. Prostaglandins regulate acid-induced cell-mediated bone resorption. Am J Physiol Renal Physiol 2000; 279: F1077-82.
28. Bushinsky DA, Nilsson EL. Additive effects of acidosis and parathyroid hormone on mouse osteoblastic and osteoclastic function. Am J Physiol 1995; 269: C1364-70.
29. Bonjour JP. Nutritional disturbance in acid-base balance and osteoporosis: a hypothesis that disregards the essential homeostatic role of the kidney. Br J Nutr 2013; 110: 1168-77.
30. Oh MS. Irrelevance of bone buffering to acid-base homeostasis in chronic metabolic acidosis. Nephron 1991; 59: 7-10.
31. Fenton TR, Tough SC, Lyon AW, Eliasziw M, Hanley DA. Causal assessment of dietary acid load and bone disease: a systematic review & meta-analysis applying Hill's epidemiologic criteria for causality. Nutr J 2011; 10: 41.
32. Fenton TR, Eliasziw M, Lyon AW, Tough SC, Hanley DA. Metaanalysis of the quantity of calcium excretion associated with the net acid excretion of the modern diet under the acid-ash diet hypothesis. Am J Clin Nutr 2008; 88: 1159-66.
33. Fenton TR, Lyon AW, Eliasziw M, Tough SC, Hanley DA. Metaanalysis of the effect of the acid-ash hypothesis of osteoporosis on calcium balance. J Bone Miner Res 2009; 24: 1835-40.
34. Du J, Hu Z, Mitch WE. Molecular mechanisms activating muscle protein degradation in chronic kidney disease and other catabolic conditions. Eur J Clin Invest 2005; 35: 157-63.
35. Workeneh BT, Mitch WE. Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr 2010; 91: 1128S-32S.
36. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 1996; 97: 1447-53.
37. May RC, Kelly RA, Mitch WE. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 1986; 77: 614-21.
38. Ballmer PE, McNurlan MA, Hulter HN, Anderson SE, Garlick PJ, Krapf R. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 1995; 95: 39-45.
39. Papadoyannakis NJ, Stefanidis CJ, McGeown M. The effect of the correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure. Am J Clin Nutr 1984; 40: 623-7.
40. Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 2004; 65: 1031-40.
41. Movilli E, Zani R, Carli O, et al. Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. Nephrol Dial Transplant 1998; 13: 1719-22.
42. Lim VS, Yarasheski KE, Flanigan MJ. The effect of uraemia, acidosis, and dialysis treatment on protein metabolism: a longitudinal leucine kinetic study. Nephrol Dial Transplant 1998; 13: 1723-30.
43. Pickering WP, Price SR, Bircher G, Marinovic AC, Mitch WE, Walls J. Nutrition in CAPD: serum bicarbonate and the ubiquitinproteasome system in muscle. Kidney Int 2002; 61: 1286-92.
44. Raphael KL, Zhang Y, Wei G, Greene T, Cheung AK, Beddhu S. Serum bicarbonate and mortality in adults in NHANES III. Nephrol Dial Transplant 2013; 28: 1207-13.
45. Navaneethan SD, Schold JD, Arrigain S, et al. Serum Bicarbonate and Mortality in Stage 3 and Stage 4 Chronic Kidney Disease. Clin J Am Soc Nephrol 2011; 6: 2395-402.
46. Dobre M, Yang W, Chen J, et al. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis 2013; 62: 670-8.
47. Menon V, Tighiouart H, Vaughn NS, et al. Serum bicarbonate and long-term outcomes in CKD. Am J Kidney Dis 2010; 56: 907-14.
48. Raphael KL, Wei G, Baird BC, Greene T, Beddhu S. Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney Int 2011; 79: 356-62.
49. Shah SN, Abramowitz M, Hostetter TH, Melamed ML. Serum bicarbonate levels and the progression of kidney disease: a cohort study. Am J Kidney Dis 2009; 54: 270-7.
50. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Association of serum bicarbonate levels with mortality in patients with non-dialysisdependent CKD. Nephrol Dial Transplant 2009; 24: 1232-7.
51. Driver TH, Shlipak MG, Katz R, et al. Low Serum Bicarbonate and Kidney Function Decline: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2014; 64(4): 534-41.
52. Goldenstein L, Driver TH, Fried LF, et al. Serum Bicarbonate Concentrations and Kidney Disease Progression in Community- Living Elders: The Health, Aging, and Body Composition (Health ABC) Study. Am J Kidney Dis 2014; 64(4): 542-9.
53. Lyon MD, Dunlop DM, Stewart CP. The alkaline treatment of chronic nephritis. The Lancet 1931; 218(5645): 1009-13.
54. Abramowitz MK, Melamed ML, Bauer C, Raff AC, Hostetter TH. Effects of oral sodium bicarbonate in patients with CKD. Clin J Am Soc Nephrol 2013; 8: 714-20.
55. Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994; 330: 877-84.
56. Cianciaruso B, Pota A, Pisani A, et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5--a randomized controlled trial. Nephrol Dial Transplant 2008; 23: 636-44.
57. Dunkler D, Dehghan M, Teo KK, et al. Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med 2013; 173: 1682-92.
58. Fouque D, Laville M. Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Syst Rev 2009; (3): CD001892.
59. Huang X, Jiménez-Moleón JJ, Lindholm B, et al. Mediterranean diet, kidney function, and mortality in men with CKD. Clin J Am Soc Nephrol 2013; 8: 1548-55.
60. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 2009; 20: 2075-84.
61. Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int 2010; 78: 303-9.
62. Phisitkul S, Khanna A, Simoni J, et al. Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. Kidney Int 2010; 77: 617-23.
63. Susantitaphong P, Sewaralthahab K, Balk EM, Jaber BL, Madias NE. Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review. Am J Nephrol 2012; 35: 540-7.
64. Goraya N, Simoni J, Jo C, Wesson DE. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int 2012; 81: 86-93.
65. Goraya N, Simoni J, Jo CH, Wesson DE. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol 2013; 8: 371-81.
66. Goraya N, Simoni J, Jo CH, Wesson DE. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int 2014; 86(5): 1031-8.
67. Kurtz TW, Al-Bander HA, Morris RC Jr. "Salt-sensitive" essential hypertension in men. Is the sodium ion alone important? N Engl J Med 1987; 317: 1043-8.
68. Shore AC, Markandu ND, MacGregor GA. A randomized crossover study to compare the blood pressure response to sodium loading with and without chloride in patients with essential hypertension. J Hypertens 1988; 6: 613-7.
69. Blaustein MP, Leenen FH, Chen L, et al. How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension. Am J Physiol Heart Circ Physiol 2012; 302: H1031-49.
70. Boegehold MA, Kotchen TA. Importance of dietary chloride for salt sensitivity of blood pressure. Hypertension 1991; 17: I158-61.
71. Phisitkul S, Hacker C, Simoni J, Tran RM, Wesson DE. Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors. Kidney Int 2008; 73: 192-9.
72. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease; Chapter 3: Management of progression and complications of CKD; 3.4. Acidosis. Kidney Int Suppl 2013; 3: 73-90.
73. Wright M, Jones C. Nutrition in CKD; 2. Prevention of undernutrition in CKD; Guideline 2.2. Correction of metabolic acidosis and nutrition. http://www.renal.org/guidelines/modules/ nutrition-in-ckd-sthash.Rpz4gn6y.dpbshttp://www.renal.org/ guidelines/modules/nutrition-in-ckd#sthash.Rpz4gn6y.dpbs. 2013
74. Chan M, Johnson D. Modification of lifestyle and nurtition interventions for management of early chronic kidney disease; 13. Fruit and vegetables. http://www.cari.org.au/CKD/CKDearly/Modification_of_Llifestyle_Nutrition_ECKD.pdf. 2013
75. European Renal Best Practice. http://www.european-renal-bestpractice.org/content/erbp-documents-topic. 2014.
76. Di Iorio B, Aucella F, Conte G, Cupisti A, Santoro D. A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) Study. J Nephrol 2012; 25: 437-40.
77. Gaggl M, Cejka D, Plischke M, et al. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study). Trials 2013; 14: 196.